| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 133 | 142 | 143 | 143 | 156 | 170 | 176 | 178 | 186 | 194 | 219 | 212 | 229 | 228 | 248 | 250 | 261 | 270 | 279 | 279 | 271 | 195 | 251 | 279 | 302 | 326 | 495 | 360 | 367 | 410 | 421 | 428 | 446 | 463 | 489 | 475 | 502 | 534 | 564 | 563 | 594 | 619 | 648 | 634 | 664 |
| Expenses | 115 | 123 | 127 | 125 | 131 | 144 | 149 | 150 | 153 | 162 | 180 | 180 | 191 | 198 | 213 | 222 | 231 | 228 | 238 | 234 | 236 | 176 | 218 | 245 | 343 | 272 | 292 | 342 | 302 | 336 | 345 | 349 | 365 | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 536 | 559 |
| EBITDA | 19 | 19 | 17 | 18 | 25 | 26 | 28 | 28 | 34 | 32 | 39 | 32 | 38 | 30 | 34 | 28 | 30 | 43 | 42 | 45 | 35 | 19 | 33 | 34 | -41 | 55 | 202 | 18 | 65 | 74 | 76 | 78 | 80 | 76 | 87 | 84 | 100 | 99 | 112 | 93 | 114 | 114 | 125 | 98 | 105 |
| Operating Profit % | 13 % | 13 % | 11 % | 12 % | 15 % | 14 % | 15 % | 15 % | 16 % | 15 % | 15 % | 13 % | 14 % | 13 % | 13 % | 11 % | 10 % | 15 % | 14 % | 15 % | 12 % | 8 % | 12 % | 10 % | -16 % | 16 % | 17 % | 4 % | 17 % | 18 % | 18 % | 18 % | 17 % | 16 % | 17 % | 17 % | 18 % | 17 % | 18 % | 16 % | 18 % | 17 % | 19 % | 15 % | 14 % |
| Depreciation | 10 | 11 | 11 | 11 | 12 | 13 | 14 | 15 | 15 | 15 | 17 | 18 | 21 | 20 | 21 | 22 | 23 | 34 | 35 | 38 | 42 | 39 | 40 | 42 | 38 | 38 | 38 | 41 | 41 | 40 | 41 | 41 | 42 | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 | 63 |
| Interest | 9 | 9 | 9 | 10 | 11 | 5 | 6 | 5 | 7 | 7 | 10 | 10 | 15 | 18 | 24 | 13 | 16 | 31 | 35 | 36 | 36 | 37 | 27 | 29 | 26 | 26 | 23 | 24 | 24 | 25 | 26 | 27 | 26 | 26 | 27 | 30 | 27 | 34 | 36 | 41 | 44 | 46 | 44 | 45 | 43 |
| Profit Before Tax | 0 | 0 | -1 | -1 | 2 | 8 | 8 | 8 | 12 | 10 | 12 | 4 | 2 | -8 | -10 | -7 | -8 | -23 | -27 | -28 | -42 | -57 | -32 | -35 | -104 | -9 | 142 | -46 | 1 | 10 | 10 | 11 | 13 | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 | 1 |
| Tax | 0 | -0 | -1 | 1 | -2 | 3 | 3 | 3 | 4 | 4 | 2 | 2 | 2 | -1 | -3 | -1 | 3 | -2 | -2 | 1 | 9 | -11 | -5 | -1 | 9 | 4 | 43 | 4 | -1 | 8 | 5 | 7 | 8 | 7 | 7 | 8 | 5 | 5 | 7 | -11 | 7 | 6 | -1 | 2 | -3 |
| Net Profit | 0 | 1 | -1 | -2 | 4 | 5 | 5 | 5 | 8 | 6 | 10 | 1 | -0 | -6 | -8 | -6 | -11 | -21 | -25 | -29 | -50 | -46 | -27 | -35 | -114 | -13 | 99 | -50 | 2 | 3 | 5 | 4 | 6 | 4 | 11 | 3 | 24 | 14 | 21 | 8 | 7 | 6 | 21 | -8 | 4 |
| EPS in ₹ | -0.04 | -0.07 | -0.23 | -0.30 | 0.44 | 0.59 | 0.58 | 0.63 | 0.90 | 0.55 | 1.17 | 0.37 | 0.30 | -0.39 | -0.74 | -0.71 | -0.99 | -2.05 | -2.51 | -2.57 | -4.91 | -4.48 | -1.94 | -2.33 | -8.14 | -0.76 | 8.22 | -3.55 | 0.43 | 0.44 | 0.53 | 0.54 | 0.60 | 0.55 | 0.97 | 0.41 | 1.53 | 0.87 | 1.29 | 0.50 | 0.53 | 0.34 | 1.16 | -0.68 | 0.15 |
Healthcare Global Enterprises
Healthcare Global Enterprises
637.25
-22.70
(-3.44%)
Market Cap
9,514.28 Cr
PE Ratio
431.05
Volume
2,05,589.00
Day High - Low
663.00 - 625.00
52W High-Low
799.71 - 513.30
Key Fundamentals
Market Cap
9,514.28 Cr
EPS
0.97
PE Ratio
431.05
PB Ratio
7.39
Book Value
89.21
EBITDA
414.23
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
4.93
Debt to Equity
1.78
Analyst Rating and Forecast
- By Refinitiv from6 analysts
Actual
Company News
View All News
HealthCare Global Enterprises has released the audio recording of its earnings call for Q4FY26. The call discussed audited financial results for the year ended March 31, 2026.
HealthCare Global Enterprises reported a 15% YoY revenue increase to INR 25,454 Mn for FY26. Adjusted EBITDA grew 19% to INR 4,711 Mn with an 18.5% margin.
HealthCare Global Enterprises Limited re-appoints Rajiv Maliwal as Independent Director and appoints Sanjeev Kumar as CFO effective May 25, 2026. Ravi Gothwal appointed as AVP Investor Relations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,176.50 | #1 1,17,565.52 | 59.42 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 58.48 | |
965.10 | 93,917.26 | 67.15 | 8,373.45 | 16.56 | 1,464 | 7.27 | 36.69 | |
928.45 | 70,094.09 | 68.13 | 9,127.84 | 16.28 | 1,064 | 44.26 | 45.25 | |
1,894.00 | 38,705.94 | 48.67 | 7,896.04 | #1 41.63 | 788 | 13.53 | 55.45 | |
728.35 | 37,737.35 | 89.93 | 4,643.22 | 8.32 | 384 | #1 79.65 | 49.37 | |
1,189.00 | 31,959.18 | 58.67 | 4,410.27 | 16.94 | 584 | 39.64 | 50.37 | |
758.85 | 30,364.54 | 129.70 | 3,904.60 | 27.31 | 198 | -68.80 | 56.85 | |
484.10 | 15,336.65 | 90.58 | 2,080.08 | 18.39 | 168 | 17.65 | 67.23 | |
1,380.30 | 14,018.21 | 49.67 | 1,703.08 | 8.69 | 262 | 38.41 | 70.24 | |
288.54 | 12,462.93 | #1 45.23 | 1,679.36 | 17.77 | 272 | 46.56 | 77.62 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
12.43 %
Net Income Growth
-85.33 %
Cash Flow Change
11.43 %
ROE
3.14 %
ROCE
-5.78 %
EBITDA Margin (Avg.)
-13.64 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 | 3,923 |
| Fixed Assets | 529 | 568 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 | 2,442 | 2,093 |
| Current Assets | 122 | 201 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 680 | 844 | 1,135 |
| Capital Work in Progress | 42 | 155 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 | 19 |
| Investments | 0 | 60 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 | 60 |
| Other Assets | 205 | 252 | 382 | 389 | 482 | 527 | 597 | 642 | 735 | 856 | 1,065 | 0 |
| Total Equity & Liabilities | 776 | 1,034 | 1,226 | 1,444 | 1,654 | 2,253 | 2,036 | 2,220 | 2,316 | 2,708 | 3,543 | 3,923 |
| Current Liabilities | 187 | 195 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 744 | 1,046 | 1,017 |
| Non Current Liabilities | 284 | 270 | 371 | 506 | 584 | 1,258 | 856 | 866 | 876 | 1,099 | 1,507 | 1,495 |
| Total Equity | 305 | 569 | 490 | 579 | 522 | 420 | 714 | 884 | 869 | 865 | 990 | 1,332 |
| Reserve & Surplus | 209 | 451 | 347 | 398 | 389 | 293 | 528 | 731 | 721 | 687 | 783 | 1,183 |
| Share Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 | 149 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 3 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 |
| Investing Activities | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 |
| Operating Activities | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | 285 | 317 |
| Financing Activities | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.71 % | 68.41 % | 68.40 % | 71.44 % | 71.43 % | 71.42 % | 71.39 % | 71.38 % | 71.37 % | 71.35 % | 71.30 % | 71.29 % | 71.28 % | 71.25 % | 71.23 % | 71.23 % | 71.22 % | 62.46 % | 63.78 % | 63.77 % | 64.21 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.28 % | 0.00 % | 6.74 % | 3.95 % | 4.29 % | 2.77 % | 2.45 % | 2.16 % | 3.59 % | 3.22 % | 2.75 % |
| DIIs | 7.82 % | 7.86 % | 6.27 % | 5.52 % | 4.90 % | 3.56 % | 4.03 % | 4.40 % | 5.54 % | 6.58 % | 7.94 % | 6.66 % | 8.52 % | 10.89 % | 11.64 % | 12.94 % | 12.47 % | 13.22 % | 18.36 % | 18.30 % | 18.91 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.05 % | 9.46 % | 10.83 % | 10.07 % | 10.84 % | 11.58 % | 11.21 % | 11.60 % | 11.44 % | 10.43 % | 9.96 % | 9.68 % | 9.39 % | 9.41 % | 9.33 % | 9.60 % | 10.43 % | 10.50 % | 10.41 % | 11.20 % | 10.79 % |
| Others | 14.42 % | 14.26 % | 14.50 % | 12.97 % | 12.83 % | 13.44 % | 13.38 % | 12.61 % | 11.65 % | 11.63 % | 4.52 % | 12.37 % | 4.07 % | 4.49 % | 3.50 % | 3.46 % | 3.43 % | 11.66 % | 3.86 % | 3.51 % | 3.34 % |
| No of Share Holders | 13,891 | 15,065 | 20,573 | 22,362 | 23,663 | 23,018 | 24,672 | 28,707 | 28,858 | 25,931 | 27,327 | 27,289 | 27,195 | 26,529 | 29,670 | 32,820 | 45,394 | 47,028 | 46,970 | 45,366 | 47,576 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 396.99 | 418.51 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 420.99 | 465.22 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 527.78 | 507.46 |
| 24 May 2025 | Quarterly Result Announcement | NA | 24 May 2025 | 546.92 | 591.00 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 562.82 | 617.78 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 689.78 | 646.56 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 759.65 | 737.19 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 626.77 | 605.51 |
| 02 Mar 2026 |  Rights | 1:17 | 02 Mar 2026 | 587.86 | 572.16 |
| 19 May 2026 | Quarterly Result Announcement | NA | 19 May 2026 | 572.55 | 632.25 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
9 days agoStatement Of Deviation Or Variation Of The Proceeds Of Rights Issue For The Quarter Ended March 31 2026.9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation9 days ago
9 days agoRe-Appointment Of Internal Auditor Of The Company9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in Management9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in Management9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in Directorate9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Diversification / Disinvestment9 days ago
9 days agoAudited Financial Results For The Quarter And Year Ended March 31 2026.9 days ago
9 days agoBoard Meeting Outcome for Outcome Of The Board Meeting_19.05.20269 days ago
9 days agoIntimation Regarding Launch Of New Comprehensive Cancer Hospital Of The Company In Hebbal North Bangalore.10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
May 13, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 07, 2026
May 07, 2026Board Meeting Intimation for Considering And Approving Inter-Alia The Audited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31 2026 (Financial Results).May 01, 2026
May 01, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2026
Apr 22, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 13, 2026
Apr 13, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 30, 2026
Mar 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 30, 2026
Mar 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionMar 30, 2026
Mar 30, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMar 29, 2026
Mar 29, 2026Outcome Of Rights Issue Committee- March 27 2026Mar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-AllotmentMar 27, 2026
Mar 27, 2026Intimation Regarding Winding Up Of Healthcare Global (Tanzania) Private Limited Wholly Owned Indirect Subsidiary Of The CompanyMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 06, 2026
Mar 06, 2026Letter Of Offer For Rights Issue Of Fully Paid-Up Equity SharesFeb 25, 2026
Feb 25, 2026Corporate Action- Record Date For Rights Issue.Feb 24, 2026
Feb 24, 2026Announcement under Regulation 30 (LODR)-Raising of FundsFeb 24, 2026
Feb 24, 2026Board Meeting Outcome for Outcome Of Board Meeting- Rights IssueFeb 24, 2026
Feb 24, 2026Board Meeting Intimation for Notice Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises Limited To Be Held On Tuesday February 24 2026.Feb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Raising of FundsFeb 17, 2026
Feb 17, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On February 17 2026Feb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Feb 13, 2026Audio Recording Of The Investor/Analyst Meet Held On February 09 2026.Feb 09, 2026
Feb 09, 2026Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raise By Way Of Issuance Of Equity Shares Through Rights IssueFeb 08, 2026
Feb 08, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Adoption Of HCG Employee Stock Option Scheme 2026Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 66.70
ATR(14)
Less Volatile 22.77
STOCH(9,6)
Overbought 81.50
STOCH RSI(14)
Neutral 62.91
MACD(12,26)
Bullish 2.25
ADX(14)
Strong Trend 30.52
UO(9)
Bearish 58.55
ROC(12)
Uptrend And Accelerating 6.21
WillR(14)
Overbought -5.79
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
